Why a complementary analytical toolbox is essential for correct siRNA duplex content determination.

Laure-Elie Carloni1, Tiny Deschrijver1, Kirsten Ryvers1

  • 1Therapeutics Development & Supply, Janssen Research & Development, NV, a Johnson & Johnson company, Beerse, Belgium.

PubMed
Summary

Characterizing small interfering RNA (siRNA) duplexes requires careful analytical design. This study reveals how sample preparation and chromatography can cause artifacts, impacting siRNA therapeutic analysis.